Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
6.71
+0.02 (0.30%)
Dec 20, 2024, 4:00 PM EST - Market closed
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $208.92 million as of December 20, 2024. Its market cap has increased by 74.65% in one year.
Market Cap
208.92M
Enterprise Value
25.48M
1-Year Change
74.65%
Ranking
Category
Stock Price
$6.71
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $208.92M, a decrease of -11.14%. That is a compound annual growth rate of -5.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 208.92M | 91.33% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SOPHiA GENETICS | 216.59M |
| Profound Medical | 215.83M |
| Inhibikase Therapeutics | 215.02M |
| Zentalis Pharmaceuticals | 213.80M |
| Inhibrx Biosciences | 211.35M |
| Lexeo Therapeutics | 207.65M |
| Utah Medical Products | 206.96M |
| Akso Health Group | 204.77M |